Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1820 (LINC01820)

Target
LINC01820
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Non-protein coding RNA, Other
01

Overview

Long intergenic non-protein coding RNA 1820 (LINC01820) is a member of the long intergenic non-coding RNA (lincRNA) class, defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap with annotated protein-coding genes[1][3]. LincRNAs generally function in the regulation of gene expression at multiple levels, including chromatin remodeling, genome architecture, RNA stabilization, and transcriptional control[1]. Many lincRNAs display tissue specificity and may act locally on neighboring genes or at a distance through nuclear organization[1]. While the broad class of lincRNAs has been implicated in biological processes such as enhancer activity, gene silencing, and chromatin looping, the precise function and clinical significance of LINC01820 itself remains uncharacterized in the scientific literature as of this writing[1][3]. There are no known disease associations, biomarkers, or relevant therapeutic drugs for LINC01820, and it is not considered a validated therapeutic target at this time.

Other names
LINC01820
02

Mechanism of action

None known

03

Biological functions

Gene expression regulationChromatin architecture modulationRNA stabilizationTranscriptional activation or repressionPotential enhancer-like functionsOther
04

Disease associations

Other

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1820 (LINC01820).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1820 (LINC01820).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call